Cost Effective Supplement
Quick navigation
http://www.ncbi.nlm.nih.gov/pubmed/29579828
During this follow-up, CBD was well-tolerated, and there were no severe adverse effects. Plasma levels of tacrolimus were variable. Therefore, longer follow-up is required.